高密度脂蛋白预防冠心病发生的研究进展

被引:17
作者
郭锦军
蔡久英
机构
[1] 辽宁医学院附属第一医院心内科
关键词
D O I
暂无
中图分类号
R541.4 [冠状动脉(粥样)硬化性心脏病(冠心病)];
学科分类号
100201 [内科学];
摘要
<正>脂质代谢异常是冠心病(CHD)最重要的危险因素之一。许多大规模临床研究已充分证明胆固醇特别是低密度脂蛋白胆固醇(LDL-C)在冠心病的发生发展中的重要作用,降低LDL-C能显著减少冠心病事件。近年来流行病学及大规模临床研究已经证实高密度脂蛋白(HDL)对动脉血
引用
收藏
页码:231 / 234
页数:4
相关论文
共 8 条
[1]
升高高密度脂蛋白胆固醇干预的现状与展望.[J].赵水平;.中华心血管病杂志.2007, 02
[2]
Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport [J].
Duffy, D ;
Rader, DJ .
CIRCULATION, 2006, 113 (08) :1140-1150
[3]
Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo [J].
Naik, SU ;
Wang, X ;
Da Silva, JS ;
Jaye, M ;
Macphee, CH ;
Reilly, MP ;
Billheimer, JT ;
Rothblat, GH ;
Rader, DJ .
CIRCULATION, 2006, 113 (01) :90-97
[4]
The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: A comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia [J].
Saklamaz, A ;
Comlekci, A ;
Temiz, A ;
Caliskan, S ;
Ceylan, C ;
Alacacioglu, A ;
Yesil, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (05) :677-681
[5]
Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel [J].
Shepherd, J ;
Betteridge, J ;
Van Gaal, L .
CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (05) :665-682
[6]
Current understanding of the metabolism and biological actions of HDL [J].
von Eckardstein, A ;
Hersberger, M ;
Rohrer, L .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2005, 8 (02) :147-152
[7]
Biologic therapies for dyslipidemia [J].
Davidson M.H. .
Current Atherosclerosis Reports, 2004, 6 (1) :69-72
[8]
The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: Expert group recommendations [J].
Sacks, FM .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (02) :139-+